Canopy Growth (TSE:WEED – Get Free Report) had its price objective reduced by equities researchers at Alliance Global Partners from C$1.80 to C$1.60 in a research report issued on Tuesday,BayStreet.CA reports. Alliance Global Partners’ target price would suggest a potential upside of 20.30% from the stock’s previous close.
A number of other research firms have also recently weighed in on WEED. ATB Cormark Capital Markets upgraded shares of Canopy Growth from a “sector perform” rating to an “outperform” rating and set a C$1.40 price objective for the company in a research report on Tuesday, March 17th. Canaccord Genuity Group set a C$2.00 target price on shares of Canopy Growth and gave the company a “speculative buy” rating in a research report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of C$1.88.
Get Our Latest Stock Analysis on Canopy Growth
Canopy Growth Stock Performance
Canopy Growth (TSE:WEED – Get Free Report) last announced its quarterly earnings data on Monday, June 15th. The company reported C($0.40) EPS for the quarter. Canopy Growth had a negative net margin of 107.39% and a negative return on equity of 47.41%. The business had revenue of C$71.25 million for the quarter. As a group, research analysts forecast that Canopy Growth will post -0.69 earnings per share for the current year.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
See Also
- Five stocks we like better than Canopy Growth
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
- 5 High-Yield Stocks With Analyst Support and Room to Run
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
